Ligufalimab (0.1, 1 mg/kg for Raji xenograft, 0.2 mg/kg for MDA-MB-231 xenograft model) inhibits tumor growth in mice[1].
| Animal Model: | SCID/Beige mice (Raji xenograft model, MDA-MB-231 xenograft model)[1] |
| Dosage: | 0.1, 1 mg/kg for Raji xenograft, 0.2 mg/kg for MDA-MB-231 xenograft model |
| Administration: | I.v. |
| Result: | Inhibited tumor growth with the tumor inhibition rate of 88.56%, 63.78% at 1, 0.1 mg/kg. |
